Is a gamma-glutamyl transferase (GGT) level of 680 U/L dangerous?
Under normal circumstances, glutamyl transpeptidase refers to γ-glutamyl transpeptidase (GGT). A level of 680 U/L is considered quite dangerous. The normal reference range for γ-glutamyl transpeptidase is generally between 0–40 U/L. Therefore, a GGT level of 680 U/L is significantly elevated and may be associated with factors such as drug-induced liver injury, fatty liver disease, alcoholic hepatitis, cholangitis, or cirrhosis. Patients are advised to follow medical guidance for symptomatic treatment. Specific analyses are as follows:
1. Drug-induced stimulation
If certain medications are taken regularly, they may increase the burden on the liver, leading to elevated γ-glutamyl transpeptidase activity. Usually, no specific treatment is required; discontinuing the medication promptly often leads to improvement after a period of time.
2. Fatty liver disease
This condition results from excessive fat accumulation within liver cells and commonly presents symptoms such as fatigue, discomfort in the upper right abdomen, and sleep disturbances. It may also lead to markedly elevated GGT levels. Patients can take medications such as polyene phosphatidylcholine capsules or atorvastatin calcium tablets under medical supervision to improve their condition.
3. Alcoholic hepatitis
Prolonged alcohol consumption may irritate liver cells and impair liver function, resulting in increased serum γ-glutamyl transpeptidase levels. Patients may be treated under medical guidance with medications such as silybin capsules or metadoxine capsules.
4. Cholangitis
Caused by bile duct obstruction leading to bile stasis, cholangitis may present with symptoms including abdominal pain, chills, and high fever, and may also result in elevated GGT levels. Patients can take anti-inflammatory and bile-promoting medications such as Xiyanli Dan tablets or ursodeoxycholic acid tablets as directed by a physician to improve their condition.
5. Cirrhosis
In patients with cirrhosis, severe damage to liver cells may cause elevated levels of γ-glutamyl transpeptidase in the blood. If cirrhosis is the underlying cause, medications such as entecavir tablets or tenofovir alafenamide fumarate tablets should be taken under medical supervision to manage symptoms.
Besides the above, markedly elevated GGT levels may also be related to liver cancer. If patients experience any discomfort or unusual symptoms, it is recommended that they seek timely medical evaluation at a hospital to avoid delays in diagnosis and treatment.